Диссертация (1174200), страница 50
Текст из файла (страница 50)
– 1997. – Т. 157. – № 20. –P. 2317-2321.175. Hull R.D. Relation between the time to achieve the lower limit of the APTTtherapeutic range and recurrent venous thromboembolism during heparin treatmentfor deep vein thrombosis / R.D. Hull [et al.] // Archives of Internal Medicine. –1997. – Т. 157. – № 22. – P. 2562-2568.176. Hull R.D. Low-molecular-weight heparin vs heparin in the treatment of patientswith pulmonary embolism / R.D.
Hull [et al.] // Archives of internal medicine. –2000. – Т. 160. – № 2. – P. 229-236.177. Husted S. Non-vitamin K antagonist oral anticoagulants (NOACs): no longer newor novel / S. Husted [et al.] // Thrombosis and haemostasis. – 2014. – Т. 112. –№ 5. – P. 781-782.178. Hyers T.M. Antithrombotic therapy for venous thromboembolic disease / T.M.Hyers [et al.] // Chest. – 1998. – Т. 114. – № 5. – P. 561S-578S.179.
Hyers T.M. Antithrombotic therapy for venous thromboembolic disease / T.M.Hyers [et al.] // Chest. – 2001. – Т. 119. – № 1. – P. 176S-193S.180. Imberti D. Direct oral anticoagulants for extended treatment of venousthromboembolism: insights from the EINSTEIN CHOICE study. / D. Imberti, F.Pomero, D. Mastroiacovo // Blood transfusion. Trasfusione del sangue. – 2019.
–P. 1-8.181. Jacobs D.G. The role of vena caval filters in the management of venousthromboembolism / D.G. Jacobs, R.F. Sing // The American Surgeon. – 2003. –Т. 69. – № 8. – P. 635-642.182. Jaff M.R. Management of massive and submassive pulmonary embolism,iliofemoral deep vein thrombosis, and chronic thromboembolic pulmonary304hypertension: a scientific statement from the American Heart Association / M.R.Jaff [et al.] // Circulation. – 2011.
– Т. 123. – № 16. – P. 1788-1830.183. Jia Z. Caval penetration by inferior vena cava filters: a systematic literature reviewof clinical significance and management / Z. Jia [et al.] // Circulation. – 2015. –Т. 132. – № 10. – P. 944-952.184. Jiang J. The short-term efficacy of vena cava filters for the prevention ofpulmonary embolism in patients with venous thromboembolism receivinganticoagulation: Meta-analysis of randomized controlled trials / J. Jiang, Y.
Jiao,X. Zhang // Phlebology. – 2017. – Т. 32. – № 9. – P. 620-627.185. Joels C.S. Complications of inferior vena cava filters / C.S. Joels, R.F. Sing, B.T.Heniford // The American Surgeon. – 2003. – Т. 69. – № 8. – P. 654-659.186. JohnsenH.S.[etal.].D-DimerMeasuredatDiagnosisofVenousThromboembolism is Associated with Risk of Major Bleeding // TH Open.
2019.№ 01 (3). C. e77–e84.187. Jost C.J. [et al.]. Surgical reconstruction of iliofemoral veins and the inferior venacava for nonmalignant occlusive disease // Journal of vascular surgery. 2001. № 2(33). C. 320-328.188. Kahn S.R. The postthrombotic syndrome: evidence-based prevention, diagnosis,and treatment strategies: a scientific statement from the American HeartAssociation / S.R.
Kahn [et al.] // Circulation. – 2014. – Т. 130. – № 18. – P. 16361661.189. Kahn S.R. Relationship between deep venous thrombosis and the postthromboticsyndrome / S.R. Kahn, J.S. Ginsberg // Archives of internal medicine. – 2004. –Т. 164. – № 1. – P. 17-26.190. Kakkar A.K. Prevention of venous thromboembolism in cancer patients / A.K.Kakkar, R.C. Williamson // Seminars in thrombosis and hemostasis. – 1999.
–Т. 25. – P. 239-243.191. Kakkar V.V. Prevention and management of venous thrombosis / V.V. Kakkar //British medical bulletin. – 1994. – Т. 50. – № 4. – P. 871-903.305192. Kakkar V.V. Low-molecular-weight heparin in the acute and long-term treatmentof deep vein thrombosis / V.V.
Kakkar [et al.] // Thrombosis and haemostasis. –2003. – Т. 89. – № 04. – P. 674-680.193. Kardys C.M. The use of intravascular ultrasound imaging to improve use ofinferior vena cava filters in a high-risk bariatric population / C.M. Kardys [et al.] //Journal of vascular surgery. – 2007. – Т. 46.
– № 6. – P. 1248-1252.194. Kaufman J.A. Guidelines for the use of retrievable and convertible vena cavafilters: report from the Society of Interventional Radiology multidisciplinaryconsensus conference / J.A. Kaufman [et al.] // World journal of surgery. – 2007. –Т. 31. – № 2. – P. 251-264.195. Kearon C. Extended Low-Intensity Anticoagulation for Thrombo-EmbolismInvestigators. Comparison of low-intensity warfarin therapy with conventionalintensity warfarin therapy for long-term prevention of recurrent venousthromboembolism / C. Kearon [et al.] // N Engl J Med. – 2003. – Т. 349.
– № 7. –P. 631-639.196. Kearon C. Antithrombotic therapy for VTE disease: antithrombotic therapy andprevention of thrombosis: American College of Chest Physicians evidence-basedclinical practice guidelines / C. Kearon [et al.] // Chest. – 2012. – Т. 141. – № 2. –P. 419S-496S.197. Kearon C. Antithrombotic therapy for VTE disease: CHEST guideline and expertpanel report / C. Kearon [et al.] // Chest.
– 2016. – Т. 149. – № 2. – P. 315-352.198. Kendoff D. Oral thromboprophylaxis following total hip or knee replacement:review and multicentre experience with dabigatran etexilate / D. Kendoff [et al.] //The open orthopaedics journal.
– 2011. – Т. 5. – P. 395-399.199. Khorana A.A. Venous thromboembolism and prognosis in cancer / A.A. Khorana// Thrombosis research. – 2010. – Т. 125. – № 6. – P. 490-493.200. Kidane B. The use of prophylactic inferior vena cava filters in trauma patients: asystematic review / B. Kidane [et al.] // Injury. – 2012. – Т. 43. – № 5. – P. 542547.306201. Killingsworth C.D. Prospective implementation of an algorithm for bedsideintravascular ultrasound-guided filter placement in critically ill patients / C.D.Killingsworth [et al.] // Journal of vascular surgery. – 2010.
– Т. 51. – № 5. –P. 1215-1221.202. Kinney T.B. Update on inferior vena cava filters / T.B. Kinney // Journal ofvascular and interventional radiology. – 2003. – Т. 14. – № 4. – P. 425-440.203. Kirilcuk N.N. Are temporary inferior vena cava filters really temporary? / N.N.Kirilcuk [et al.] // The American journal of surgery. – 2005. – Т. 190. – № 6. –P. 864-870.204. Klevanets J. Systemic thrombolytic therapy and catheter-directed fragmentationwith local thrombolytic therapy in patients with pulmonary embolism / J.Klevanets [et al.] // Annals of vascular surgery.
– 2017. – Т. 45. – C. 98-105.205. Klok F.A. Prospective cardiopulmonary screening program to detect chronicthromboembolic pulmonary hypertension in patients after acute pulmonaryembolism / F.A. Klok [et al.] // haematologica. – 2010. – Т. 95. – № 6.
– P. 970975.206. Klok F.A. Evaluation of the predictive value of the bleeding prediction scoreVTE‐BLEED for recurrent venous thromboembolism / F.A. Klok [et al.] //Research and practice in thrombosis and haemostasis. – 2019. – Т. 3. – № 3. –P. 364-371.207. Knudson M.M. Thromboembolism after trauma: an analysis of 1602 episodes fromthe American College of Surgeons National Trauma Data Bank / M.M. Knudson[et al.] // Annals of surgery. – 2004. – Т. 240.
– № 3. – P. 490-496.208. Knudson M.M. Hospital-specific risk factors for filter fever / M.M. Knudson //JAMA surgery. – 2013. – Т. 148. – № 7. – P. 687-688.209. Kölbel T. Thrombus embolization into IVC filters during catheter-directedthrombolysis for proximal deep venous thrombosis / T. Kölbel [et al.] // Journal ofEndovascular Therapy. – 2008. – Т. 15.
– № 5. – P. 605-613.307210. Konstantinides S. Importance of cardiac troponins I and T in risk stratification ofpatients with acute pulmonary embolism / S. Konstantinides [et al.] // Circulation.– 2002. – Т. 106. – № 10. – P. 1263-1268.211. Konstantinides S. Authors/Task Force Members. 2014 ESC Guidelines on thediagnosis and management of acute pulmonary embolism: the Task Force for theDiagnosis and Management of Acute Pulmonary Embolism of the EuropeanSociety of Cardiology (ESC) Endorsed by the European Respiratory Society (ERS)/ S. Konstantinides [et al.] // Eur Heart J. – 2014.
– Т. 35. – № 43. – P. 3033-73.212. Konstantinides S.V. Impact of thrombolytic therapy on the long-term outcome ofintermediate-risk pulmonary embolism / S.V. Konstantinides [et al.] // Journal ofthe American College of Cardiology. – 2017. – Т. 69. – № 12. – P. 1536-1544.213. Koopman M.M. Treatment of venous thrombosis with intravenous unfractionatedheparin administered in the hospital as compared with subcutaneous lowmolecular-weight heparin administered at home / M.M. Koopman [et al.] // NewEngland Journal of Medicine. – 1996. – Т. 334.
![](https://s.studizba.com/z.php?f=/templates/si/i/noavatar.png&w=100&h=100&t=1"){kind=avatar}
